Paying user area
Try for free
Merck & Co. Inc. pages available for free this week:
- Income Statement
- Common-Size Income Statement
- Analysis of Profitability Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Enterprise Value (EV)
- Current Ratio since 2005
- Total Asset Turnover since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Merck & Co. Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Statement
| 12 months ended: | Sales | Net income attributable to Merck & Co., Inc. |
|---|---|---|
| Dec 31, 2025 | ||
| Dec 31, 2024 | ||
| Dec 31, 2023 | ||
| Dec 31, 2022 | ||
| Dec 31, 2021 | ||
| Dec 31, 2020 | ||
| Dec 31, 2019 | ||
| Dec 31, 2018 | ||
| Dec 31, 2017 | ||
| Dec 31, 2016 | ||
| Dec 31, 2015 | ||
| Dec 31, 2014 | ||
| Dec 31, 2013 | ||
| Dec 31, 2012 | ||
| Dec 31, 2011 | ||
| Dec 31, 2010 | ||
| Dec 31, 2009 | ||
| Dec 31, 2008 | ||
| Dec 31, 2007 | ||
| Dec 31, 2006 | ||
| Dec 31, 2005 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Over the period examined, sales exhibited a generally increasing trend, though not consistently. Initial growth from 2005 to 2007 was followed by a slight decrease in 2008. A significant surge in sales occurred in 2010, more than doubling the previous year’s figure, and continued at a high level through 2019. A substantial increase is again observed in 2022 and 2023, continuing the overall upward trajectory. Net income attributable to Merck & Co., Inc. demonstrated considerably more volatility than sales.
- Sales Trend
- From 2005 to 2007, sales increased from US$22,012 million to US$24,198 million, representing a compound annual growth rate of approximately 5.3%. Following a minor dip in 2008, sales experienced substantial growth in 2010, reaching US$45,987 million. This growth appears to be partially attributable to a significant event in that year, as it represents a considerable deviation from prior trends. Sales remained relatively stable between approximately US$40 billion and US$49 billion from 2011 through 2019. A further substantial increase occurred in 2022 and 2023, reaching US$60,115 million and US$64,168 million respectively.
- Net Income Trend
- Net income began at US$4,631 million in 2005 and fluctuated considerably over the subsequent years. A notable decline occurred between 2005 and 2007, falling to US$3,275 million. A significant increase was then observed in 2009, reaching US$12,901 million, mirroring the sales surge in 2010. However, net income then plummeted to US$861 million in 2010. From 2011 to 2015, net income varied between approximately US$3.9 billion and US$6.3 billion. A peak was reached in 2014 at US$11,920 million, followed by a decline to US$2,394 million in 2017. Net income recovered in 2018 and 2019, reaching US$9,843 million. A substantial increase is observed in 2021, reaching US$13,049 million, followed by a dramatic decrease in 2022 to US$365 million, before recovering significantly in 2023 to US$17,117 million.
- Relationship between Sales and Net Income
- While a general positive correlation between sales and net income is expected, the observed relationship is not consistently strong. The large increase in sales in 2010 did not translate into a proportional increase in net income; in fact, net income decreased substantially. Similarly, the sales growth from 2018 to 2019 did not result in a commensurate increase in net income. The significant decline in net income in 2022, despite increased sales, suggests potential pressures on profitability, such as increased costs or other expenses. The substantial recovery in net income in 2023, alongside continued sales growth, indicates a potential improvement in these factors.
The volatility in net income suggests that factors beyond revenue generation significantly influence the company’s profitability. Further investigation into cost of goods sold, operating expenses, and other income statement items would be necessary to fully understand the drivers of these fluctuations.
Balance Sheet: Assets
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2025 | ||
| Dec 31, 2024 | ||
| Dec 31, 2023 | ||
| Dec 31, 2022 | ||
| Dec 31, 2021 | ||
| Dec 31, 2020 | ||
| Dec 31, 2019 | ||
| Dec 31, 2018 | ||
| Dec 31, 2017 | ||
| Dec 31, 2016 | ||
| Dec 31, 2015 | ||
| Dec 31, 2014 | ||
| Dec 31, 2013 | ||
| Dec 31, 2012 | ||
| Dec 31, 2011 | ||
| Dec 31, 2010 | ||
| Dec 31, 2009 | ||
| Dec 31, 2008 | ||
| Dec 31, 2007 | ||
| Dec 31, 2006 | ||
| Dec 31, 2005 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
The company’s current assets exhibited fluctuating behavior between 2005 and 2025. Total assets experienced a significant shift in 2009, followed by a period of relative stabilization before increasing substantially in later years.
- Current Assets Trend
- Current assets began at US$21,049 million in 2005, decreasing to US$15,230 million in 2006, and continuing to decline slightly to US$15,045 million in 2007. A moderate increase was observed through 2009, reaching US$28,429 million. These assets then remained relatively stable, fluctuating between approximately US$29,000 million and US$35,700 million from 2010 to 2017. A noticeable decrease occurred between 2017 and 2018, falling to US$25,875 million, followed by a gradual increase to US$30,266 million in 2020. Further growth was seen in 2021 and 2022, peaking at US$35,722 million before decreasing to US$32,168 million in 2023. The most recent figures show a substantial increase to US$43,516 million in 2025.
- Total Assets Trend
- Total assets remained relatively consistent between 2005 and 2008, fluctuating between US$44,570 million and US$48,351 million. A dramatic increase occurred in 2009, reaching US$112,090 million, followed by a decrease to US$105,781 million in 2010. From 2010 to 2014, total assets experienced a gradual decline, reaching US$98,335 million. A slight recovery was observed in 2015, followed by a more pronounced decline to US$82,637 million in 2018. Total assets then began to increase, reaching US$91,588 million in 2019 and continuing to grow to US$109,160 million in 2022. The most recent period shows a significant increase to US$136,866 million in 2025.
- Relationship between Current and Total Assets
- Throughout the period, current assets consistently represented a portion of total assets. The proportion varied, but generally remained between 20% and 50%. The substantial increase in total assets in 2009 did not correspond to a similar increase in current assets, suggesting acquisitions or other non-current asset investments contributed significantly to the change. The recent increases in both current and total assets from 2020 to 2025 indicate a potential strengthening of the company’s short-term liquidity position alongside overall asset growth.
Balance Sheet: Liabilities and Stockholders’ Equity
Merck & Co. Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
| Current liabilities | Total debt | Total Merck & Co., Inc. stockholders’ equity | |
|---|---|---|---|
| Dec 31, 2025 | |||
| Dec 31, 2024 | |||
| Dec 31, 2023 | |||
| Dec 31, 2022 | |||
| Dec 31, 2021 | |||
| Dec 31, 2020 | |||
| Dec 31, 2019 | |||
| Dec 31, 2018 | |||
| Dec 31, 2017 | |||
| Dec 31, 2016 | |||
| Dec 31, 2015 | |||
| Dec 31, 2014 | |||
| Dec 31, 2013 | |||
| Dec 31, 2012 | |||
| Dec 31, 2011 | |||
| Dec 31, 2010 | |||
| Dec 31, 2009 | |||
| Dec 31, 2008 | |||
| Dec 31, 2007 | |||
| Dec 31, 2006 | |||
| Dec 31, 2005 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
An examination of the balance sheet items reveals distinct trends in current liabilities, total debt, and stockholders’ equity over the period from 2005 to 2025. Current liabilities generally increased over the timeframe, though not consistently. Total debt exhibited significant fluctuations, with a notable increase in 2009, followed by periods of decline and subsequent growth. Stockholders’ equity demonstrated a substantial surge in 2009, followed by a general decline until 2018, before experiencing a recovery in later years.
- Current Liabilities
- Current liabilities began at US$13,304 million in 2005 and decreased to US$12,258 million by 2007. A subsequent increase was observed, reaching US$18,348 million in 2012. Following this peak, current liabilities decreased to US$17,204 million in 2016, then increased again, reaching US$28,420 million in 2023 before decreasing slightly to US$28,327 million in 2024 and increasing to US$28,420 million in 2025. This suggests a generally upward trend with intermediate fluctuations.
- Total Debt
- Total debt decreased from US$8,098 million in 2005 to US$5,739 million in 2007. A significant increase occurred in 2009, rising to US$17,454 million, likely due to a specific financing event. Debt levels fluctuated between approximately US$17 billion and US$26 billion from 2010 to 2015. A further increase was observed from 2019 to 2021, peaking at US$33,102 million, before decreasing to US$30,691 million in 2022. The most recent years show a substantial increase, reaching US$49,339 million in 2025, indicating a considerable reliance on debt financing.
- Stockholders’ Equity
- Stockholders’ equity remained relatively stable between 2005 and 2008, fluctuating around US$18 billion. A dramatic increase occurred in 2009, reaching US$59,058 million, likely attributable to a significant event impacting equity. Following 2009, a consistent downward trend was observed, with equity declining to US$25,907 million by 2019. A recovery began in 2020, with equity increasing to US$38,184 million, and continued through 2025, reaching US$52,606 million. This suggests a period of equity erosion followed by a recent strengthening of the equity position.
The interplay between these three balance sheet items suggests a shifting financial strategy. The increase in debt, particularly in recent years, coupled with the initial decline in stockholders’ equity, may indicate a period of increased financial leverage. The subsequent recovery in equity, however, suggests a strengthening of the company’s financial foundation. The fluctuations in current liabilities likely reflect normal operating cycles and short-term financing needs.
Cash Flow Statement
| 12 months ended: | Net cash provided by operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
|---|---|---|---|
| Dec 31, 2025 | |||
| Dec 31, 2024 | |||
| Dec 31, 2023 | |||
| Dec 31, 2022 | |||
| Dec 31, 2021 | |||
| Dec 31, 2020 | |||
| Dec 31, 2019 | |||
| Dec 31, 2018 | |||
| Dec 31, 2017 | |||
| Dec 31, 2016 | |||
| Dec 31, 2015 | |||
| Dec 31, 2014 | |||
| Dec 31, 2013 | |||
| Dec 31, 2012 | |||
| Dec 31, 2011 | |||
| Dec 31, 2010 | |||
| Dec 31, 2009 | |||
| Dec 31, 2008 | |||
| Dec 31, 2007 | |||
| Dec 31, 2006 | |||
| Dec 31, 2005 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Over the period examined, the company demonstrates fluctuating cash flow patterns across operating, investing, and financing activities. Operating cash flow exhibits considerable variability, while investing and financing activities show distinct trends and significant shifts in cash usage.
- Operating Activities
- Net cash provided by operating activities generally remained positive throughout the period, though with substantial fluctuations. Initial values ranged between approximately US$6.5 billion and US$7.6 billion (2005-2009). A significant increase is observed in 2010, reaching US$10.8 billion, followed by further increases in 2011 and 2012. A decline occurred in 2013 and 2014, before recovering to over US$12 billion in 2015. A notable decrease to US$6.4 billion occurred in 2017, followed by a recovery and then a substantial peak in 2022 at US$19.1 billion. The most recent years, 2023 and 2024, show values of US$13.0 billion and US$21.5 billion, respectively, indicating a recent upward trend.
- Investing Activities
- Net cash flow from investing activities is characterized by significant volatility. From 2006 to 2008, the company consistently used cash in investing activities, with the largest outflow occurring in 2006 at negative US$4.9 billion. A period of cash inflow from investing activities is seen in 2009 and 2017, but is generally outweighed by outflows. The period from 2019 to 2021 shows a dramatic increase in cash used for investing, peaking at negative US$16.4 billion in 2021. While outflows remain substantial in 2022 and 2023 (negative US$4.96 billion and negative US$14.08 billion respectively), they are lower than the 2021 peak. The most recent year, 2024, shows a continued outflow of negative US$7.7 billion.
- Financing Activities
- Net cash flow from financing activities consistently demonstrates cash outflows throughout the majority of the period. Outflows generally ranged between US$3 billion and US$6 billion annually from 2005 to 2016. A particularly large outflow occurred in 2014, reaching negative US$15.1 billion. A brief period of cash inflow is observed in 2021 (US$3.1 billion), but is followed by substantial outflows in 2022 and 2023 (negative US$9.1 billion and negative US$4.8 billion respectively). The trend continues in 2024 with an outflow of negative US$7.0 billion. The consistent negative values suggest ongoing activities such as debt repayment, share repurchases, or dividend payments.
The company’s cash flow profile suggests a dynamic financial strategy. The substantial fluctuations in operating cash flow may be linked to business performance and working capital management. The significant and often negative cash flow from investing activities indicates considerable capital expenditure or acquisitions. The consistent negative cash flow from financing activities suggests a reliance on external funding sources or a commitment to returning capital to shareholders.
Per Share Data
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2025 | |||
| Dec 31, 2024 | |||
| Dec 31, 2023 | |||
| Dec 31, 2022 | |||
| Dec 31, 2021 | |||
| Dec 31, 2020 | |||
| Dec 31, 2019 | |||
| Dec 31, 2018 | |||
| Dec 31, 2017 | |||
| Dec 31, 2016 | |||
| Dec 31, 2015 | |||
| Dec 31, 2014 | |||
| Dec 31, 2013 | |||
| Dec 31, 2012 | |||
| Dec 31, 2011 | |||
| Dec 31, 2010 | |||
| Dec 31, 2009 | |||
| Dec 31, 2008 | |||
| Dec 31, 2007 | |||
| Dec 31, 2006 | |||
| Dec 31, 2005 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.
The per share information reveals fluctuating performance over the period examined. Basic and diluted earnings per share demonstrate considerable volatility, while dividend per share exhibits a consistent upward trajectory.
- Earnings Per Share (Basic & Diluted)
- From 2005 to 2008, basic earnings per share decreased from $2.11 to $1.51, then experienced a substantial increase to $3.66 in 2008. This was followed by a peak of $5.67 in 2009, before plummeting to $0.28 in 2010. The subsequent years showed recovery, with earnings per share fluctuating between $2.04 and $4.12 between 2011 and 2014. A decline to $1.58 in 2015 and $1.42 in 2016 was observed, followed by a decrease to $0.88 in 2017. Earnings per share then increased to $2.34 in 2018 and $3.84 in 2019, before reaching $2.79 in 2020 and a high of $5.16 in 2021. A significant drop occurred in 2022, with earnings per share falling to $0.14. A substantial recovery was then seen in 2023 and 2024, reaching $6.76 and $7.30 respectively. The latest reported value for 2025 is $7.28. Diluted earnings per share mirrored this pattern closely.
- Dividend Per Share
- Dividend per share remained constant at $1.52 from 2005 through 2010. Beginning in 2011, a steady increase is apparent, rising to $1.56, then $1.69, $1.73, $1.77, $1.81, and $1.85 through 2016. This upward trend continued with dividends of $1.89 in 2017, $1.99 in 2018, $2.26 in 2019, $2.48 in 2020, $2.64 in 2021, $2.80 in 2022, $2.96 in 2023, $3.12 in 2024, and $3.28 in 2025. This demonstrates a consistent commitment to returning value to shareholders through increasing dividend payments.
The divergence between earnings per share and dividend per share is notable. While earnings per share experienced significant fluctuations, the dividend per share consistently increased, suggesting a policy of maintaining or growing dividend payments even during periods of lower profitability. This could indicate a confidence in future earnings potential or a strategic decision to prioritize shareholder returns.